ChapterVIIBioactive substances and medicinal effects of the REISHI, and polyporacea fungi
1.General chemical components in REISHI
Takashi MIZUNO
Examples of the analysis of general components and free amino acid composition in Mannentake fruiting body (REISHI) are shown in Table 1 and Table 2.
As
a matter of course, differences in the contents of the components were
found between naturally grown and artificially cultivated samples of REISHI.Differences
were also found in the chemical composition both quantitatively and qualitatively
depending on the lines, places of the production, cultivation conditions,
etc. of REISHI.
2.Medicinal
effects of REISHI extract with hot water
Takashi MIZUNO
Table 3 shows the medicinal effects of decocted solution and its extract (yield, ca. 10% per dry REISHI) obtained from REISHI, which has been told from generation to generation as an oriental drug (Sanyaku).Little has been studied on the isolation of pure substances having these medicinal effects. Studies on the pharmacologically active substances have grown prosperous recently as the culture and cultivation of Mannentake became possible.These active substances are described below in order. Among them, antitumor substances whose properties have recently studied well will especially be described later in the Chapter VIII in detail.
3.Bitter
Terpenoides
Tsuyoshi NISHITOBA
The
fruiting body of Mannentake (REISHI) has a remarkably strong bitterness
that cannot be found in any other mushroom and the bitterness varies in
quality depending on the place of production, cultivation conditions, its
strains, etc.On the contrary, such
bitterness cannot be found in cultured mycelia or substances produced in
the culture medium, and Kokushi (black REISHI, see Chapter V-4.1) does
not contain the bitter substance. Though relationship between the bitterness
and the pharmacological effect has not fully been revealed yet, the bitterness
attracts attention as a marker substance for pharmacological evaluation
and chemical quality judgment of REISHI and chemical classification of
Ganoderma
sp.
As
the bitter components and related compounds, 45 lanostane triterpenoids
(35 of them being novel compounds) have been isolated from ethanol extracts
of REISHI by various chromatographic means (6).
Some
other triterpenoids isolated from Mannentake have also been studied on
their antiallergy action (10), antiandrogen action (11),
antigypertensive action, (12) Etc.
A
lot of highly oxidized lanostane triterpenoids, some of bitter principles,
were isolated from the fruiting body of the fungus Ganoderma lucidum
(REISHI)
(13,
14).This fungus produces
bitterness during the course of fruiting, and was classified in at least
two types, one is C30 ganoderic acid type and the other is C27
lucidenic acid type (15).Fig.
1 and Table
4show the structures of some triterpenoid components and theirbitterness.Whilethe
relationshipbetweenthe
chemicalstructure and bitterness
has not so far been clarified, it was pointed out that theoxygenfunctional
groups (16) and the hydrophobic moieties (17,
18) played significant roles in generating bitterness.In
thecase of G. lucidumbitterness,
it was revealed that they have a similarity in their chemical structures
and the spatial distances amongthree
oxygen atoms and thehydrophobicmethyl
groupsplayedan
important role.Fig.
2 represents the structural similarity between lucidenic acid A
and lucidone A, both of whichshowedalmostthe
same bitterness.Among the bitter
terpenoids of G. lucidum, ganoderic acids A, B, C1 and
C2 have inhibitory activity on histamine release from rat mast
cells (19), and ganoderic acids B and C2 have
ACE-inhibitory activity. (20)
The
bitter triterpenoids were also obtained from the fruiting body of Ganoderma
applanatum, whose structures resembled those of G. lucidum (Fig.
3) (21).Taste
threshold values for ganoderenic acids A, G and furanoganoderic acid were
obtained to be 1x10-5 (M), 1x10-6 (M) and 1x10-6
(M),
respectively.
Crytoporus volvatus, belonging to polyporaceae, shows a bitter taste and drimane sesquiterpenoid ethers, cryptoporic acids A-G (Fig. 4), were obtained from the fruiting body of the fungus(22-24).Dimeric cryptoporic acids C, E, F and G showed the inhibitoryactivity on the release of02-from guinea-pig perituneal macrophage.
4.Steroids
(25)
Takashi
MIZUNO
0.3-0.4%
of ergosterol (provitamin D2) to be contained in REISHI has
been reported.However, further analysis
has confirmed that main component of the steroid fraction was 24-methyl-cholesta-7,
22-dien-3beta-ol and ergosterol and 24-methylchol-est-7-en-3-beta-ol were
subcomponents.Recently, ganodesterone
hasbeen isolated as a steroid.
5.Nucleotides
(26)
Takashi
MIZUNO
Like other mushrooms, REISHI contains adenosine, 5'-GMP, 5'-XMP,RNA, etc. as basic components, all ofthem being related to taste (deliciousness, Umami).It has been found recently that nucleotides, such as adenosine and guanosina in a water/alcohol extract of REISHI were possessed of a platelet aggregation inhibition action (antithrombotic activity) (95).
6. Hypoglycemic
proteoglycans
Masashi
TOMODA
The
hypoglycemic activity of the crude drug "REISHI", the dried fruiting body
of Ganoderma lucidum,hasbeenclinically
recognized.However, nohypoglycemic
principle has been reported until 1985.
6.1Isolation
and characterization of Ganoderans A and B (27)
The
material collected in Kanagawa was extracted with hot water.The
extract was poured into ethanol, and the solution of theprecipitate
obtained was successively applied to columns of DEAE-Toyopearl650M,
Sepharose 6B, and sephacryl S-200 or Sephadex G-50 to isolate two glycans
which are designated asganoderans
A and B.They were homogeneous on
electrophoresis and gel chromatography, and their molecular weights were
estimated to be about 23,000 and 7,400, respectively.
The major constituent of ganoderan A is a neutral polysaccharide composed of galactose: glucose: rhamnose in the molar ratio of 10:7:4.Ganoderan B is substantially a glucan, although small amounts of mannose and hexuronic acids were found in it. The presence of acetyl groups in them was also indicated (2.5% and 1.0%, respectively).In addition, they contain peptide moieties.The amounts were 2.6% in ganoderan A and 17.5%in ganoderan B.
6.2Measurement
of hypoglycemic activity (28,29)
Male
mice (Std:ddY strain, 25-30g) were used in groups of five.The
samples were dissolved in physiological saline solution and administered
by i.p. injection into normal mice or into alloxan-induced hyperglycemic
mice.Blood was drawn periodically
from the orbital sinus by microhaematocrit tubes. The
glucose level of plasma obtained by centrifugation of blood was measured
with a glucose analyzer by the glucose oxidase method.
Ganoderan A had potent hypoglycemic affect.Ganoderan B showed a little weaker activity than ganoderan A (Table 5). i.p. administration of ganoderans A and B to alloxan-hyperglycemic mice also reduced plasma glucose level (Table 6).
6.3Isolation,
characterization and activity of Ganoderans B (Kyoto) and C (38)
The
hot water extract obtained from the crude drug produced in Kyoto was fractionated
by ethanol precipitation and by successive chromatography withDEAE-Toyopearl
650M, Sephacryl S-200 and Sephadex G-50.In
this case, two proteoglycans, ganoderans B and C, ware isolated.Each
of them gave a clear single band on PAGE and a single peak on gel chromatography.In
each case, bothPAS and Coomassie
blue reagents visualized a bandin
the same position on PAGE.Their
molecular weights were estimated to be about 7,400 and 5,800 respectively.
Ganoderan
B (Kyoto) was composed of a glucan and a peptide moiety (5:4).Ganoderan
C was composed of a neutral polysaccharide and a peptide moiety (28.4:10).The
polysaccharide moiety of the latter was composed of glucose and galactose
(24:1).
The
hypoglycemic potency of ganoderan B (Kyoto) was approximately the same
as that of previous sample (kanagawa). The activity of ganoderan C was
slightly less than that of ganoderan B (Table
7).I.p. injection of ganoderan
C to alloxan-induced hyperglycemic mice also lowered the blood glucose
level but theactivity was less than
those of ganoderans A and B (after 7h, 75%;after
24h, 112% of the control).
6.4Structural
features of the polysaccharide moieties of Ganoderans B and C (38)
Ganoderan
B (Kyoto) exhibited a negative specific rotation and its 1H-NMR
apectrum showed two anomeric signals at4.52
(d, J=7 Hz)and4.75
(d, J=7 Hz).Among the
signals in its 13 C-NMR spectrum, those at 63.46 and 71.63 were
attributable to the C-6, those at 78.28 and 87.26to the C-3, and thatat
105.25 to theC-1 carbons.Therefore,
it can be concluded, that the beta-D-glucose residues are linked at the
1,3 and 6 positionsin GanoderanB.
In
each substance, a carbohydrate-rich moiety was isolated by treatment with
a protease followed by gel chromatography.These
fractions obtained were permethylated,then
the products were hydrolyzed and converted into the partially
methylated alditol acetates.GC-MS
revealed derivatives of2, 3, 4,
6-tetra-O-methyl glucose, 2, 4,6-tri-O-methyl
glucose, 2, 3, 4-tri-O-methylglucose
and 2,4-di-O-methyl glucose as the products from Ganoderan B in a molar
ratio of 1.0:1.1:2.0:1.1.Ganoderan
Cgave derivatives of
2, 3, 4, 6-tetra-O-methy glucose, 2, 4, 6-tri-O-mathy glucose, 2, 3, 4-tri-0-methyl
glucose, 2, 3, 4-tri-O-methyl galactose and2,
4-di-0-methylglucose
in a molar ratio of 1.0:1.0:2.1:0.2:1.1.These
results were also supported by values of the residual sugar after periodate
oxidation of the substances.
Recently,
the presence of a backbone chain composed of beta-1,3-linked glucan in
several polysaccharides having antitumor activity obtained from this crude
drug wasreported
(29-31).
Based on the evidence described above and theseresults,
it can beconcluded thatbeta-1,
6-linked side chains are attached to thebeta-1,3-linkedglucan
backbone in Ganoderans B and C (Fig.
5), and that Ganoderan C has additional beta-1,6-linked D-galactosyl
units.The presence ofbeta-1,6-linked
oligomerside chains
in Ganoderans B and C is unique as compared with the other glucans from
this crude drug.
6.5Activity
of the other heteroglycans (32)
Mizuno
et al. (30,33)
separated a number of heteroglycans having
antitumor effects from another variety of the same crude drug produced
in Miyazaki and Shiga.The hypoglycemic
effects of these heteroglycans are shown in Table
8.
7.Blood
pressure stabilizing components (12, 34~36)
Takashi
MIZUNO
REISHI has been assumed to have both hypotensive and hypertensivecomponents (the so-called homeostasis).A peptidoglycan (molecular weight, 100,000) having a mild hypotensive effect on Wister rats and SHR rats(congenitally hypertensive) has been isolated from a hot water extract of REISHI. According to a report, the blood pressure of about half the patients of essential hypertension was reduced when a REISHI extract was administered to them.It was found recently that a hypertension-related angiotensin-I-converting enzyme was inhibited by Ganoderic acids (B, D, F, H, R, S and Y); Ganoderal A and Ganoderol A and B.
8.Germanium
(Ge) components (37)
Takashi
MIZUNO
Ithasbeen
noted for a long time that crude drugs of a ginseng, a polyporaceae, etc.
treasured as oriental drugs havehigh
Ge contents (Table
9).Especially, a property
to concentrate Ge was confirmed in Mannentake(38). Recently,
a polysaccharide beta-(1-->3)-D-glucanand
its protein complex having remarkable antitumor activity have been isolatedfrom
Mannentake (ref. Chapter VIII).Correlation
between this antitumor activity (interferon inducing activity) and Ge contents
is also drawing attention because, especially, Ge is said to have a function
to neutralize pain of final symptoms of cancer.
We have analyzed Ge contents and mineral compositions in natural andcultivated mushroom samples of Polyporales and cultivated REISHI samples collected at various districts in Japan, by means of an inductively coupled plasmaanalysis (ICP method) (Table 10).The Ge contents in the samples analyzed by uswere low ( 10 - 100 ppb; average, 50 ppb ).In other words, none of them showedthe high Ge contents so far reported ( 10 - 4,000 ppm ).On the contrary, it was confirmed that the Ge contents in REISHI became significantly high when it was cultivated using a bed log which has been absorbed with organic Ge (Go-132) (Table 11).
9.Platelet
aggregation inhibitor
Hirokazu
KAWAGISHI
Some compounds have been isolated from mushrooms as platelet aggregation inhibitor (Table 12 and Fig. 6).We have also isolated and identified adenosine and guanosine as potent inhibitors from Ganoderma lucidum.
10.Lectins
Hirokazu
KAWAGISHI
The
term "lectin" (from the latin legere, to pick up, choose) is defined
as a (carbohydrate) protein of non-immune origin which agglutinates cells
or precipitates polysaccharides or glycoconjugates (42).Many
species of animals, plants and microorganisms contain lectins.Among
these species, relatively few studies have been conducted on lectins from
mushrooms (43-45).
Table 13 presents some properties of lectins isolated from mushrooms.There is no report of isolation of glucose-, mannose-, or their derivatives-specific lectin from mushrooms.Here describes some properties of the lectins which were isolated from the order Polyporales.
10.1Ischnoderma
resinosum agglutinin (IRA) (46)
This is a first isolated beta-galactosyl-specific lectin from fungi.IRA was purified from the fruiting body of Ischnoderma resinosum by affinity chromatography on Sepharose 4B.The lectin is composed of two identical subunits of 16 KDa. beta-galactosyl-specific lectins have been isolated from various plants (47, 48), animals (49-51) and microorganism (52).Although at higher concentration, most are also inhibited by N-acetylgalactosamine in hemagglutination inhibition assay.But IRA is completely inert to it up to a concentration of 200 mM (Table 14).These results indicate that this lectin strictly recognizes the C-2 hydroxy group in galactosyl residues.
10.2Grifola
frondosa lectin (GFL) (53)
An
N-acetylgalacotsamine-specific lectin (GFL) was isolated from Grifola
frondosa fruiting body by affinity chromatography on acid-treated Sepharose
CL-4B and then N-acetylgalactosamine-Toyopearl.The
isolated lectin agglutinated all types of erythrocytes equally. Molecular
weight estimated by gel filtration under various buffers and matrices
varied from 30 to 52 KDa. On the other hand, SDS-PAGE in the presence or
absence of 2-mercaptoethanol showed three major bands of 33, 66 and 100
KDa and a faint band of 65 KDa. This lectin exhibited N-acetylgalactosamine-specificity
(Table 15); in hemagglutination-inhibition assay, both anomers of methyl
N-acetylgalactosaminide were the most potent inhibitors. N-acetylgalactosamine
and its alpha-(1-->4)-linked oligomers, GalNAc-[alpha-(l-->O4)GalNAc]n
(n=1-7), exhibited the same inhibitory activity. Among the glycoproteins
tested, hemagglutination by GFL was more strongly inhibited by asialobovine
submaxillary mucin (BSM), which has terminal N-acetylgalactosamine residues
in O linked sugar chains, than native BSM which have subterminal Nacetylgalactosamine
residues in the chains. Asialofetuin, which have O-glycosidically and N-glycosylically
linked sugar chains, inhibited the agglutination at higher concentration
than asialoBSM or BSM did. Native fetuin is much less effective than
asialo-one. The other glycoproteins, alpha-acid glycoprotein and tranferrin,
did not inhibit the hemagglutination at all. These results suggest that
the lectin is specific for terminal N-acetylgalactosamine residue and subterminal
N-acetylgalactosamine residue did not affect the specificity strongly.
GFL is cytotoxic against HeLa cells; the minimum concentration giving complete death of the cells for the lectin was 25 ug/ml. After preincubaing GFL with the haptenic sugar N-acetylgalactosamine, the lectin did not exhibit the toxicity. In addition, GFL was toxic both after and before adherence of the cells to the culture substratum. These results show that the cytotoxicity of the lectin against HeLa cells is concerned with binding the lectin to the sugar chains on the cells, and independent on aggregation of the cells by the lectin.
10.3 A
lectin from Fomes fomentarius (FFL)(54)
A
lectin of Fomes fomentarius is N-acetylgalactosamine-specific and
B type erythrocytes-specific. The lectin has a molecular weight of 70 kDa
and exhibited an unusual high content of sugar (25%) and extreme viscosity
of its solution (up to a concentration over 0.1%).
10.4 Ganoderma
lucidum lectins(GLLS)
Investigation
of lectins from Ganoderma lucidum is now being carried out by us.
We have isolated lectins from not only the fruiting body but also the mycelia
of this fungus (55). Both lectins have different molecular
weights and amino acid compositions. This mycelia-lectin is the first
isolated one from other than fruiting body of higher fungi.
11. Antitumor substances in REISHI
11.1Cytotoxic
terpenoids
Tsuyoshi NISHITOBA
Cultured
mycelia of Ganoderma lucidum also produce a number of lanostane
triterpenoids, whose oxidative mode was somewhat different from that of
the fruiting body’s components.(74 -83) Toth et al. revealed
that ganoderic acids U - Z have cytotoxicity on hepatoma cells grown in
vitro (74 – 75). On the other hand, Hirotani et al. presented
the interesting result that ganoderic acids R and S are strongly antihepatotoxic
in using galactosamine induced cytotoxicity (76).
From
the fungus
Paria cocos lanostane triterpenoids, pachymic and tumulosic
acids, their 7, 9(11) - dehydro derivatives and polyprenic acid C. were
obtained and their methyl esters showed cytotoxicity on cultured hepatoma
cells (85).
Coriolus
consors produces
sesquiterpenoids, coriolins. Coriolin and diketocoriolin B, which was obtained
by oxidizing coriolin B, showed antibacterial and antitumor activities
(86,
87).
Fomannosin
and fomannoxin isolated from Fomes annosus were reported to have
antibacterial and phytotoxic activities (88, 89).
The
chemical structures of the active compounds mentioned here are represented
in Chapter VIII-9 (Terpenoid).
11.2Host-mediated
antitumor polysaccharides (1, 90, 91-94)
Takashi
MIZUNO
Among
polymer components in REISHI, many polysaccharides were extracted using
hot water, ammonium oxalate solution, alkali solution, dimethyl sulfoxide
(DMSO) solution, etc. and purified into pure fractions by various chromatographic
means. These fractions were used for the screening of host-mediated antitumor
activities (BRM substances and immunotherapeutic agents) by a Sacroma 180/mice,
ip or po method. As the result, strong antitumor activities were found
in various hetero-beta-D-glucans having beta-(1à3)-D-glucan
chain as the active site, such as beta-D-glucan, glucurono-beta-D-glucan,
arabinoxylo-beta-D-glucan, xylo-beta-D-glucan, manno-beta-D-glucan and
xylomanno-beta-D-glucan, as well as their protein complexes. These polysaccharides,
especially in REISHI, are expected to be used as materials for the development
of new antitumor agents (immunity enhancers), because they have no drug
toxicity or strong secondary effect which are common in chemotherapeutic
agents, in addition to the absence of antigegecity in them (Table
16).
In
addition, polysaccharides having immunomodulated antitumor activities or
anti-inflammation functions are contained not only in water-soluble beta-D-glucans
but also in hemicellulose (the so-called dietary fiber) fraction which
is water-insoluble and can be extracted with alkali or DMSO in high yield.
In
addition to these active polysaccharides, many other polysaccharides have
been isolated or reported to exist, such as alpha-(là6);
alpha-(1à4)-D-glucan
(glycogen-like polysaccharide), fucogalactan, mannofucogalactan, fucoxylomannan
and xylomannoarabinogalactan, though none of them showed antitumor activity.
Since
these non-active polysaccharides exist together with the active beta-D-glucans
in REISHI, it is assumed that they are concerned with solubility, protection
and digestion and absorption of the active glucans.
Like the other mushrooms, the polysaccharides of cellular wall of REISHI are composed of not cellulose but chiefly chitin and beta-D-glucans. The chitin (fungal chitin) is basically the same as the animal chitin in shrimps, crabs, insects, etc. Mushroom chitin and chitosan were water-insoluble. When N-acetylchitooligosaccharides (DP, 2 - 8) and chitooligosaccharides (DP, 2 - 8) obtained by hydrolyzing these chitin and chitosan with an acid or an enzyme were analyzed by the Sacroma 180/mice, i.p. method, no antitumor activity was found (90).
11.3Extracellular
polysaccharides of Mannentake (2)
Takashi
MIZUNO
Polysaccharides
were produced extracellularly when Mannentake mycelia were shakeing
cultured using a liquid medium (pH 6.8) containing monosaccharides (glucose,
galactose, mannose, xylose, etc.) and disaccharides (sucrose, maltose and
lactose) as the carbon source (5%), malt extracts (0.4%), yeast extracts
(0.1%) and mineral salts (Table
17).
Dried polysaccharides thus obtained were separated into water-insoluble (47%) and soluble (53%) fractions. The water-insoluble polysaccharide fraction contained a beta-(1à3)-D-glucan having beta-(là6) branches (Fig. 7; branching ratio, 1:27). When this glucan was administered to mice (10 mg/kg x 10, i.p.), it showed high antitumor activity with the suppression ratio percentage of tumor proliferation being 92% and the complete regression ratio being 4/6. The antitumor activity of this glucan was improved by its modification to polyol polysaccharide (5 mg/kg x 10, i.p. administration showed the suppression ratio of 97% and the regression ratio of 5/7). The water-soluble fraction, on the other hand, contained a heteroglucan composed of glucose, mannose and galactose (1.0 : 0.5 : 0.13 in molar ratio) having no antitumor activity.
12.Stamina
buildup by the REISHI extract
Hiroshi
FUJIWARA
This paper describes the effect of REISHI extraction on stamina buildup.Running distance and endurance by animal training groups were used to determine whetherREISHI effected on stamina buildup. To my knowledge, no data have been published on the relationships between REISHI extraction and stamina buildup.
12.1Methods
One
hundred and eighty four healthy young to adult female, male albino of the
ddY strain, and 136 healthy young to adult female, male albino rats of
the Sprague-Dawley strain were used.
They
were divided into four groups; 45, 90, 180 days wheel running group and
8-weeks tread-mill running group. Wheel running group was divided further
into eight groups: 0.25%, 0.5% REISHI drinking groups and the water drinking
groups (control) by male and female. These eight groups were given wheel
running training spontaneously. 8-weeks tread-mill running groups were
divided into 8 groups with 0.25% REISHI drinking and water drinking
group (control) by male and female mice and rats.
They
were selected from a littersize in the mice and rats.
They
had been kept in the conditioning room under the temperature 22.0±2.0C,
humidity 50.0±4.0% for all experimental period.
Wheel
running and tread-mill both apparatus were designed by author. The size
of diameter is 19.7cm, and length of circumference is 62cm for mice
wheel running apparatus. The other size of diameter is 31.9cm and length
of circumference is 100cm for rats wheel running apparatus.
These
are shown in Fig.
8.
The
length of running lane of tread-mill is 47cm, and width of running lane
is 7cm, electric shocker set at the back of lane, and the distance gotten
by one rotation is 100cm in this tread mill.
The
tread-mill diagram is shown in Fig.9,
Fig
10, and Fig.
11.
Wheel
running distance was taken by rotating counter of wheel running apparatus
during the entire day.
The tread-mill training was carried out by the running speed (belt speed) controlled with 30m/min for the mice, and 45m/min for the rats in the tread-mill.
Running
distance of REISHI drinking group was much longer than that of control
group in case of 0.5% concentration drinking.
These data are shown in Table 19.
3.In
the 180 days wheel run training mice groups, mean running distance were
25616±3316m in case of 0.25% REISHI drinking female group, 21095±2725m
in water drinking female group (control), 25291±3442m In 0.25% REISHI
drinking female group, and 20636±2329m in water drinking female
group (control), 30284±3224m in 0.5% REISHI drinking female group,
21975±3196m in water drinking group (control), 27972±3257m
in 0.5% REISHI drinking male group, and 21816±3044m in water drinking
group (control) at each 208-days—old animals.
Running
distance of REISHI drinking group were much longer than that of control
group in case of 0.5% REISHI concentration drinking.
The
wheel running distance of 45, 90 and 180 days groups of mice was significant
(p«0.05-p«0.01) compared with control groups.
These data are shown in Fig. 12.
4.In
the 45 days training rats groups, mean running distance were 13379±1450m
in 0.25% REISHI drinking female group, 12047±1616m in water drinking
female group (control), 12360±1483m in 0.5% REISHI drinking male
group, and 11426±l502m in water drinking male group at each 73-days-old
animals.
Statistically
significant difference was found between REISHI and control group (p<0.05-p<0.01).
These
data are shown in Table
20.
5.In
the 90 days training rats groups, mean running distance were 24981±2300m
in 0.25% REISHI drinking female group, 19670±2083m in water drinking
female group (control), 22895±2513m in REISHI drinking male group,
and 20284±2304m in water drinking group (control) at each 118-days-old
animals.
Running
distance of REISHI drinking group was much longer than that of control
group in case of 0.25% REISHI drinking.
Statistically
significant difference was found between REISHI drinking group and control
group (p<0.01).
These data are shown in Table 21.
6.In
the 8-weeks tread-mill training mice groups, mean running distance (until
exhaustion) were 4005±243m in 0.25% REISHI drinking female group,
3880±229m in water drinking female group (control), 3891±237w
in 0.25% REISHI drinking male group, and 3603±237m in water drinking
male group (control).
Running
distance of female and male mice was much longer than that of control group
in case of REISHI drinking.
Statistically
significant difference was found between REISHI and control group (p<0.OS).
These data are shown in Table 22.
7.In
8-weeks tread-mill training rats groups, mean running distance (until exhaustion)
were 5635±747m in 0.25% REISHI drinking female group. 4869±1999m
in water drinking female group (control), 5499±789m in 0.25% REISHI
drinking male group, and 4783±1089m in water drinking male group
(control).
Statistically
significant difference was found between REISHI and control group (p<0.05).
Further,
female endurance ability was greater than male in the mice and rats.
These data are shown in Fig. 13 and Table 23.
12.3
Discussion
The
effect of REISHI drinking on the buildup of running capacity has been
examined through training mice and rats on the wheel running and tread-mill
apparatus.
These
animals were administrated in the REISHI and water. The relation between
running distance and number of training days was significant; the result
of 180 days group showed longer distance than those of 45, 90 days group
in the wheel running.
But,
the REISHI drinking group showed more significant effect on buildup than
the water drink group, and extended more running distance according to
the number of training days. Stamina buildup by REISHI extract was
confirmed in this experiment, Compared with endurance ability of female
and male, the female animals jogged more than male animals every time.
It
is expected that these data would offer the good indicator for the people
who are interested in the problem of physical fitness.